Showing results (61-70 of 629) with videos related to
Sort By:
Pageof 63
Interventional Cardiology Clinics|November 26, 2016
Pretreatment with Antiplatelet Agents in the Setting of Percutaneous Coronary Intervention: When and Which Drugs?Davide Capodanno, Dominick J AngiolilloJACC. Cardiovascular Interventions|April 7, 2021
Antithrombotic Management of Elderly Patients With Coronary Artery DiseasePiera Capranzano, Dominick J AngiolilloCirculation|November 30, 2020
Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes MellitusDavide Capodanno, Dominick J AngiolilloInterventional Cardiology Clinics|June 6, 2017
Basics of Antithrombotic Therapy for Cardiovascular Disease: Pharmacologic Targets of Platelet Inhibitors and AnticoagulantsPiera Capranzano, Dominick J AngiolilloExpert Opinion on Biological Therapy|December 22, 2017
Canakinumab for secondary prevention of atherosclerotic diseaseDavide Capodanno, Dominick J AngiolilloThe American Journal of Cardiology|March 12, 2021
Aspirin for Primary Prevention of Cardiovascular Disease in the 21st Century: A Review of the EvidenceDominick J Angiolillo, Davide CapodannoFrontiers in Cardiovascular Medicine|September 12, 2022
De-escalation of antiplatelet therapy in acute coronary syndromes: Why, how and when?Mattia Galli, Dominick J AngiolilloItalian Heart Journal. Supplement : Official Journal of the Italian Federation of Cardiology|December 11, 2003
[Past, present, and future of intracoronary brachytherapy]Dominick J Angiolillo, Manel SabatéAmerican Heart Journal|July 31, 2008
Pharmacology of emerging novel platelet inhibitorsDominick J Angiolillo, Piera CapranzanoAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|July 27, 2010
Platelet P2Y₁₂ receptor inhibition: an update on clinical drug developmentDavid Vivas, Dominick J AngiolilloPageof 63